Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06023641
What this trial is testing

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Who this might be right for
Rhabdomyosarcoma
St. Jude Children's Research Hospital 135
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Large-scale testing (Phase 3)Looking for participantsNCT04031677
What this trial is testing

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Who this might be right for
Retroperitoneal SarcomaLiposarcomaLeiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC 250
Testing effectiveness (Phase 2)Ended earlyNCT04530487
What this trial is testing

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Who this might be right for
Desmoplastic Small Round Cell TumorEwing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Desmoplastic Small Round Cell Tumor+9 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT03548428
What this trial is testing

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)

Who this might be right for
SarcomaRadiosurgery
Centre Antoine Lacassagne 103
Large-scale testing (Phase 3)Study completedNCT00038311
What this trial is testing

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Who this might be right for
Sarcoma
Pfizer 120
Testing effectiveness (Phase 2)Looking for participantsNCT06287398
What this trial is testing

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+4 more
Australasian Leukaemia and Lymphoma Group 39
Testing effectiveness (Phase 2)Study completedNCT01474681
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Novartis Pharmaceuticals 27
Testing effectiveness (Phase 2)Ended earlyNCT04996004
What this trial is testing

Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Pfizer 76
Not applicableActive Not RecruitingNCT01737619
What this trial is testing

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
M.D. Anderson Cancer Center 101
Testing effectiveness (Phase 2)Study completedNCT03245151
What this trial is testing

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

Who this might be right for
Recurrent and Refractory Solid Tumors
Eisai Inc. 64
Not applicableStudy completedNCT06802510
What this trial is testing

The Safety and Efficacy of Combined Microwave Ablation During Limb-sparing Surgery in High-risk Soft Tissue Sarcoma Patients

Who this might be right for
SarcomaMicrowaveAblation Techniques
Guangdong Provincial People's Hospital 44
Testing effectiveness (Phase 2)UnknownNCT02359474
What this trial is testing

Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin

Who this might be right for
Sarcoma
Ludwig-Maximilians - University of Munich 120
Testing effectiveness (Phase 2)Study completedNCT03338959
What this trial is testing

Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaRecurrent Soft Tissue Sarcoma
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT03241745
What this trial is testing

Nivolumab in Selected Uterine Cancer Patients

Who this might be right for
Uterine CancerEndometrial CarcinomaCarcinosarcoma+4 more
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00304083
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neurofibromatosis Type 1Sarcoma
Sarcoma Alliance for Research through Collaboration 48
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Looking for participantsNCT06544265
What this trial is testing

SynKIR-310 for Relapsed/Refractory B-NHL

Who this might be right for
B Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more
Verismo Therapeutics 36
Testing effectiveness (Phase 2)Ended earlyNCT03116529
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Maryland, Baltimore 22
Testing effectiveness (Phase 2)Study completedNCT00565721
What this trial is testing

A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis

Who this might be right for
High-grade GliomaLung CancerHead & Neck Cancer+2 more
GE Healthcare 33
Next Page